Mark J. Newman
2021
In 2021, Mark J. Newman earned a total compensation of $248.8K as Chief Scientific Officer at GeoVax Labs, a 150% increase compared to previous year.
Compensation breakdown
| Bonus | $50,000 |
|---|---|
| Option Awards | $73,759 |
| Salary | $125,000 |
| Total | $248,759 |
Newman received $125K in salary, accounting for 50% of the total pay in 2021.
Newman also received $50K in bonus and $73.8K in option awards.
Rankings
In 2021, Mark J. Newman's compensation ranked 11,808th out of 12,405 executives tracked by ExecPay. In other words, Newman earned more than 4.8% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 11,808 out of 12,405 | 5th |
Division Manufacturing | 5,203 out of 5,494 | 5th |
Major group Chemicals And Allied Products | 2,277 out of 2,369 | 4th |
Industry group Drugs | 2,019 out of 2,090 | 3rd |
Industry Pharmaceutical Preparations | 1,488 out of 1,537 | 3rd |
Source: SEC filing on June 12, 2023.
Newman's colleagues
We found two more compensation records of executives who worked with Mark J. Newman at GeoVax Labs in 2021.